AceView offers a comprehensive annotation of human, mouse and nematode genes
reconstructed by co-alignment and clustering of all publicly available
mRNAs and ESTs on the genome sequence. Our goals are to offer a reliable
up-to-date resource on the genes, their functions, alternative variants,
expression, regulation and interactions, in the hope to stimulate
further validating experiments at the bench
This site normally requires a frame enabled viewer,
However, click here to access our full description of gene FAM111BandFAM111A.
, go to our main page or see our latest news
Homo sapiens complex locus FAM111BandFAM111A, encoding family with sequence similarity 111, member A and family with sequence similarity 111, member B.
TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Compact gene diagram
Alternative mRNAs are shown aligned from 5' to 3' on a virtual genome where introns have been shrunk to a minimal length. Exon size is proportional to length, intron height reflects the number of cDNAs supporting each intron. Introns of the same color are identical, of different colors are different. 'Good proteins' are pink, partial or not-good proteins are yellow, uORFs are green. 5' cap or3' poly A flags show completeness of the transcript.
Read more...
Mouse over the ending of each transcript gives tissues from which the supporting cDNAs were extracted. Details on tissue of origin for each intron and exon is available from the
intron and exons table.
Click on any transcript to open the specific mRNA page, to see the exact cDNA clone support and eventual SNPs and to get details on tissues, sequences, mRNA and protein annotations. Proteins supported by a single continuous cDNA sequence lead to underlining the name/ending of the variant. Names not underlined result from cDNA concatenation in the coding region and should be experimentally checked.
Introns are depicted by broken lines; the height of the top of each intron reflects the relative number of clones supporting this intron.
]^[ A pink broken line denotes an intron with standard boundaries (gt-ag or gc-ag) that is exactly supported (i.e. a cDNA sequence exactly matches the genome over 16 bp, 8 on both sides of the intron).
] ^ ] A blue broken line denotes non-standard introns, exactly supported, but with non-standard at-ac or any other boundaries.
]-[ Pink and
] - ] blue straight lines represent 'fuzzy' introns of the standard and non-standard types respectively, those introns do not follow the 16 bp rule. Black straight lines ]-[denote gaps in the alignments.
Exons: Wide filled pink areas represent putative protein coding regions, narrow empty pink boxes represent the 5'UTR (on the left) and 3' UTR (on the right). Flags identify validated endings: cap site on the 5' side, polyadenylation site on the 3' side. Filled flags correspond to frequent events while empty flags have lesser supporting cDNAs (yet all are validated); at the 3' side, black flags are associated to the main AATAAA signal,
blue flags to any single letter variant of the main . More explanations are given in the
gene help file
Expression and GenBank cDNA support
Tissues where expression was observed (from 380 cDNA clones)
Origin of the cDNAs, as reported in GenBank/dbEST (tissue, stage, pathological or normal) shows that the gene is expressed in colon (seen 17 times), germinal center B cell (15), lung (14), uterus (14), brain (12), prostate (11), kidney (10), lymph (10), thymus (10), testis (9), embryonal carcinoma, cell line (8), placenta (8), breast normal (7), head neck (7), breast carcinoma (6), eye (6), parathyroid gland (6), parathyroid tumor (6), spleen (6), trachea (6), breast (5), embryonic stem cells, dmso-treated H9 cellline (5), b-cell, chronic lymphotic leukemia (4), carcinoid (4), embryonic stem cells, cell lines H1, H7, andh9 (4), hippocampus (4), leiomyosarcoma (4), tongue, tumor tissue (4), 2 pooled tumors (clear cell type) (3), adenocarcinoma (3), bone (3), bone marrow (3), chondrosarcoma (3), left pubic bone (3), liver and spleen (3), melanocyte (3), pancreas (3), pooled, cerebellum, kidney, placenta,testis, lung, colon, liver, heart, thyroid, bladder,uterus, PCR rescued clones (3), skin (3), testis, embryonal carcinoma (3), uterus tumor (3), adrenal gland (2), amygdala (2), bladder (2), carcinoma, cell line (2), cervical carcinoma cell line (2), cervix (2), fetal eyes, lens, eye anterior segment,optic nerve, retina, retina foveal and macular, RPE andchoroid (2), human placenta (2), leg muscle (2), liver (2), lymphoma, cell line (2), marrow (2), melanotic melanoma (2), moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors (2), osteosarcoma, cell line (2), ovary (2), ovary, tumor tissue (2), pooled human melanocyte, fetal heart, andpregnant uterus (2), pooled lung and spleen (2), pooled pancreas and spleen (2), primary lung epithelial cells (2), skeletal muscle (2), small cell carcinoma (2), stomach (2), stomach, tumor tissue (2), thalamus (2), tumor (2), well-differentiated endometrialadenocarcinoma, 7 pooled tumors (2), whole brain (2), adipose (once), adrenal cortex carcinoma, cell line (once), amnion normal (once), ascites (once), bladder, carcinoma (once), blood (once), breast cancer (once), burkitt lymphoma (once), colon tumor, RER+ (once), colon ins (once), denis drash (once), dorsal root ganglia (once), duodenal adenocarcinoma, cell line (once), embryonal carcinoma (once), embryonic stem cell, retinoic acid andmitogen-treated hes cell line H7 (once), fetal brain (once), fetal eyes (once), fibrotheoma (once), from acute myelogenous leukemia (once), glioblastoma (once), head normal (once), heart (once), human chondrosarcoma cell line (once), human skeletal muscle (once), hypernephroma, cell line (once), ileal mucosa (once), lacrimal gland (once), lung, spleen, fetal, pooled (once), lung tumor (once), malignant melanoma, metastatic to lymphnode (once), mammary gland (cancer tissue) (once), multiple sclerosis lesions (once), nervous tumor (once), normal prostate (once), pancreas, spleen, adult pooled (once), pheochromocytoma (once), placenta normal (once), pooled colon, kidney, stomach (once), pooled germ cell tumors (once), pooled, 40 cell lines (once), pooled-glandular (once), pooled-skin (once), poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors (once), primary lung cystic fibrosis epithelialcells (once), primitive neuroectoderm (once), prostate normal (once), prostate tumor (once), retina (once), rpe/choroid (once), senescent fibroblast (once), serous papillary carcinoma, high grade, 2pooled tumors (once), small intestine (once), sympathetic trunk (once), synovial membrane tissue from rheumatioidarthritis (once), t-lymphocytes (once), thymus, pooled (once), uterus endothel, primary cell culture (once).
380 cDNA clones support the 28 variants of gene FAM111BandFAM111A
?
This table helps analyze the pattern of expression of the gene, the tissue, cell type or disease state specificity of the alternative variants and to select cDNA clones suitable for your experiments.
cDNA accession Links to the sequence |
Tissue
most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features |
Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
NM_198947.3 | | .a | 1 to 3559 | 1 to 3559 | exact | RefSeq, AAA | | 3559/3559 (100 %) | 0 diff (100 %id) |
DC378673 | | .a | 6 to 571 | 1 to 566 | | tiling clone, | | 566/566 (100 %) | 0 diff (100 %id) |
AA278964 | germinal center B cell | .a | 10 to 393 | 1 to 384 | | | | 384/384 (100 %) | 0 diff (100 %id) |
CN365985 | embryonic stem cells, cell lines H1, H7, andH9 | .a | 22 to 722 | 1 to 701 | | | | 701/701 (100 %) | 6 diff (99.2 %id) |
DR002339 | fetal brain | .a | 23 to 607 | 12 to 595 | | | | 584/595 (98 %) | 12 diff (98.0 %id) |
AW500244 | lymph | .a | 44 to 591 | 8 to 555 | | | | 548/555 (98 %) | 6 diff (99.0 %id) |
TI_154154376 | | .a | 44 to 689 | 81 to 725 | | | | 645/645 (100 %) | 13 diff (98.0 %id) |
BF207688 | bladder, carcinoma, cell line | .a | 50 to 736 | 1 to 685 | | available from MGC, | | 685/686 (99 %) | 7 diff (99.0 %id) |
BC005998 | Bladder, carcinoma | .a | 51 to 1060 | 1 to 1009 | | available from MGC, AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 1009/1029 (98 %) | 2 diff (99.9 %id) |
AY457926 | | .a | 52 to 3540 | 1 to 3490 | exact | tiling clone, | | 3490/3490 (100 %) | 2 diff (100.0 %id) |
DA655955 | | .a | 52 to 624 | 2 to 575 | | capped | | 574/574 (100 %) | 2 diff (99.7 %id) |
AK304258 | trachea | .a | 53 to 2777 | 1 to 2725 | exact | | | 2725/2725 (100 %) | 0 diff (100 %id) |
DA961722 | Spleen | .a | 53 to 605 | 2 to 554 | | capped | | 553/553 (100 %) | 1 diff (99.9 %id) |
DC417429 | trachea | .a | 53 to 643 | 1 to 591 | | | | 591/591 (100 %) | 0 diff (100 %id) |
DA653623 | | .a | 54 to 585 | 2 to 533 | | capped | | 532/532 (100 %) | 1 diff (99.9 %id) |
DA819099 | | .a | 54 to 610 | 2 to 558 | | capped | | 557/557 (100 %) | 0 diff (100 %id) |
DA819920 | | .a | 54 to 621 | 2 to 569 | | capped | | 568/568 (100 %) | 0 diff (100 %id) |
DB165407 | thymus | .a | 54 to 636 | 2 to 584 | | capped | | 583/583 (100 %) | 0 diff (100 %id) |
DB246715 | | .a | 54 to 789 | 2 to 731 | | capped | | 730/760 (96 %) | 10 diff (98.7 %id) |
DN918245 | | .a | 67 to 680 | 1 to 614 | | | | 614/614 (100 %) | 2 diff (99.7 %id) |
BF028721 | bladder, carcinoma, cell line | .a | 69 to 752 | 1 to 686 | | | | 686/750 (91 %) | 37 diff (95.1 %id) |
BC130513 | Pooled, cerebellum, kidney, placenta,testis, lung, colon, liver, heart, thyroid, bladder,uterus, PCR rescued clones | .a | 111 to 2913 | 1 to 2803 | exact | tiling clone, | | 2803/2803 (100 %) | 0 diff (100 %id) |
BC130539 | Pooled, cerebellum, kidney, placenta,testis, lung, colon, liver, heart, thyroid, bladder,uterus, PCR rescued clones | .a | 111 to 2913 | 1 to 2803 | exact | | | 2803/2803 (100 %) | 0 diff (100 %id) |
BC144078 | Pooled, cerebellum, kidney, placenta,testis, lung, colon, liver, heart, thyroid, bladder,uterus, PCR rescued clones | .a | 111 to 2914 | 1 to 2803 | A273H L274Y Q275N Q276R D278I ... | | | 2803/2803 (100 %) | 3 diff (99.9 %id) |
TI_2194645545 | | .a | 113 to 1251 | 52 to 1173 | | | | 1122/1263 (88 %) | 66 diff (94.8 %id) |
TI_2194646167 | | .a | 113 to 1220 | 54 to 1153 | | | | 1100/1271 (86 %) | 21 diff (98.4 %id) |
TI_1607547197 | | .a | 113 to 1217 | 70 to 1188 | | | Submitted on the opposite strand | 1119/1224 (91 %) | 43 diff (96.5 %id) |
TI_1607547725 | | .a | 113 to 1061 | 137 to 1085 | | | Submitted on the opposite strand | 949/1086 (87 %) | 22 diff (98.0 %id) |
BU431066 | lymph | .a | 276 to 595 | 1 to 320 | | | | 320/320 (100 %) | 24 diff (92.5 %id) |
AA278305 | germinal center B cell | .a | 744 to 1083 | 340 to 1 | | | | 340/340 (100 %) | 1 diff (99.8 %id) |
NM_001142704.1 | | .b | 1 to 3347 | 1 to 3347 | exact | RefSeq, AAA | | 3347/3347 (100 %) | 0 diff (100 %id) |
DC353500 | brain | .b | 53 to 609 | 1 to 557 | | tiling clone, | | 557/557 (100 %) | 1 diff (99.9 %id) |
BU431348 | lymph | .b | 172 to 749 | 1 to 578 | | tiling clone, | | 578/578 (100 %) | 5 diff (99.2 %id) |
TI_154153261 | | .b | 178 to 788 | 79 to 689 | | | | 611/611 (100 %) | 2 diff (99.7 %id) |
T79574 | liver and spleen | .b | 324 to 839 | 532 to 1 | | | | 532/533 (99 %) | 30 diff (94.4 %id) |
DN918246 | | .b | 357 to 857 | 501 to 1 | | | | 501/501 (100 %) | 1 diff (99.9 %id) |
AW014033 | | .b | 445 to 883 | 442 to 4 | | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 439/442 (99 %) | 0 diff (100 %id) |
TI_1607547865 | | .b | 451 to 1612 | 1 to 1149 | | | | 1149/1265 (90 %) | 31 diff (97.6 %id) |
TI_2194646920 | | .b | 452 to 1571 | 1 to 1112 | | | | 1112/1253 (88 %) | 17 diff (98.7 %id) |
TI_2194646916 | | .b | 520 to 1691 | 1 to 1150 | | | | 1150/1252 (91 %) | 28 diff (97.8 %id) |
TI_1607547857 | | .b | 521 to 1613 | 1 to 1082 | | tiling clone, | | 1082/1233 (87 %) | 19 diff (98.5 %id) |
AA960844 | pooled | .b | 577 to 937 | 362 to 1 | | | | 362/362 (100 %) | 1 diff (99.8 %id) |
N87918 | | .b | 593 to 783 | 1 to 189 | | | | 189/190 (99 %) | 4 diff (97.9 %id) |
EC509677 | Prostate | .b | 749 to 869 | 117 to 1 | | | | 117/117 (100 %) | 4 diff (96.6 %id) |
TI_1607547871 | | .b | 999 to 2238 | 1 to 1229 | | | | 1229/1229 (100 %) | 70 diff (94.4 %id) |
TI_2194646922 | | .b | 1000 to 2092 | 9 to 1096 | | | | 1088/1264 (86 %) | 13 diff (99.0 %id) |
TI_1607547861 | | .b | 1428 to 2351 | 5 to 927 | | tiling clone, | | 923/928 (99 %) | 13 diff (98.6 %id) |
TI_2194646914 | | .b | 1437 to 2618 | 12 to 1182 | | | | 1171/1317 (88 %) | 6 diff (99.6 %id) |
TI_1607547195 | | .b | 1513 to 2702 | 1261 to 64 | | tiling clone, | Submitted on the opposite strand | 1198/1268 (94 %) | 0 diff (100 %id) |
BX279565 | embryonal carcinoma, cell line, testis | .b | 1528 to 2015 | 1 to 488 | | | | 488/488 (100 %) | 0 diff (100 %id) |
BG390686 | embryonal carcinoma, cell line, testis | .b | 1529 to 2132 | 1 to 609 | | | | 609/929 (65 %) | 18 diff (98.1 %id) |
TI_2194646168 | | .b | 1540 to 2702 | 1245 to 76 | | | | 1170/1248 (93 %) | 0 diff (100 %id) |
FN065596 | breast carcinoma | .b | 1589 to 1695 | 7 to 118 | | | | 112/118 (94 %) | 6 diff (95.0 %id) |
TI_2194645926 | | .b | 1627 to 2702 | 1138 to 71 | | | | 1068/1264 (84 %) | 0 diff (100 %id) |
TI_2194646543 | | .b | 1677 to 2702 | 1160 to 143 | | | | 1018/1303 (78 %) | 0 diff (100 %id) |
TI_1607544989 | | .b | 1713 to 2068 | 356 to 1 | | | | 356/356 (100 %) | 3 diff (99.2 %id) |
BG393116 | embryonal carcinoma, cell line, testis | .b | 1751 to 2535 | 1 to 779 | | | | 779/795 (97 %) | 15 diff (98.2 %id) |
FN097129 | breast carcinoma | .b | 1805 to 1918 | 117 to 1 | | | Submitted on the opposite strand | 117/117 (100 %) | 3 diff (97.5 %id) |
TI_2194646924 | | .b | 1859 to 2389 | 1 to 527 | | | | 527/680 (77 %) | 46 diff (93.3 %id) |
TI_1607547867 | | .b | 1885 to 2642 | 6 to 764 | | | | 759/764 (99 %) | 6 diff (99.3 %id) |
TI_1607547727 | | .b | 1919 to 2702 | 889 to 99 | | | | 791/895 (88 %) | 0 diff (100 %id) |
AI806359 | pooled | .b | 1934 to 2487 | 554 to 1 | | | | 554/554 (100 %) | 0 diff (100 %id) |
AA768088 | germinal center B cell | .b | 2068 to 2365 | 299 to 1 | | | | 299/299 (100 %) | 1 diff (99.7 %id) |
BM716746 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .b | 2302 to 2843 | 1 to 542 | | fully sequenced, | | 542/542 (100 %) | 0 diff (100 %id) |
TI_2194646923 | | .b | 2312 to 2702 | 1 to 390 | | | | 390/1301 (29 %) | 4 diff (99.7 %id) |
TI_1607547859 | | .b | 2313 to 2702 | 1 to 389 | | | | 389/884 (44 %) | 3 diff (99.7 %id) |
BF980482 | duodenal adenocarcinoma, cell line, small intestine | .b | 2362 to 3044 | 1 to 685 | | tiling clone, | | 685/939 (72 %) | 7 diff (99.3 %id) |
BF911951 | uterus_tumor | .b | 2627 to 3052 | 494 to 65 | | | Submitted on the opposite strand | 430/496 (86 %) | 0 diff (100 %id) |
BQ014206 | Chondrosarcoma, Left Pubic Bone | .b | 2785 to 3347 | 578 to 16 | | tiling clone, AAA | | 563/563 (100 %) | 0 diff (100 %id) |
BM674379 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .b | 2813 to 3347 | 549 to 16 | | fully sequenced, AAA | | 534/534 (100 %) | 2 diff (99.7 %id) |
BC062456 | Testis, embryonal carcinoma | .c | 1 to 904 | 1 to 904 | | tiling clone, available from MGC, AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 904/909 (99 %) | 8 diff (99.2 %id) |
BG613098 | embryonal carcinoma, testis | .c | 4 to 649 | 1 to 646 | | available from MGC, | | 646/646 (100 %) | 1 diff (99.9 %id) |
NM_001142703.1 | | .c | 4 to 3395 | 1 to 3392 | exact | RefSeq, AAA | | 3392/3392 (100 %) | 0 diff (100 %id) |
DC406389 | thymus | .c | 7 to 546 | 1 to 541 | | | | 541/541 (100 %) | 4 diff (99.3 %id) |
AK303520 | thymus | .c | 55 to 2418 | 1 to 2364 | I517T | tiling clone, | | 2364/2364 (100 %) | 3 diff (99.9 %id) |
DC409767 | thymus | .c | 55 to 631 | 1 to 577 | | | | 577/577 (100 %) | 2 diff (99.7 %id) |
TI_154153065 | | .c | 86 to 657 | 80 to 649 | | | | 570/570 (100 %) | 36 diff (93.7 %id) |
BU431193 | lymph | .c | 88 to 519 | 10 to 440 | | | | 431/440 (97 %) | 19 diff (95.7 %id) |
NM_001142519.1 | | .d | 1 to 3759 | 1 to 3759 | exact | RefSeq, AAA | | 3759/3759 (100 %) | 0 diff (100 %id) |
DB218857 | trachea | .d | 2 to 553 | 2 to 553 | | tiling clone, capped | | 552/552 (100 %) | 1 diff (99.9 %id) |
NM_198847.2 | | .e | 1 to 3552 | 2 to 3553 | exact | RefSeq, AAA | | 3553/3553 (100 %) | 0 diff (100 %id) |
AL702798 | human skeletal muscle | .e | 67 to 491 | 1 to 428 | | tiling clone, | | 428/428 (100 %) | 6 diff (98.6 %id) |
NM_001142520.1 | | .f | 1 to 3782 | 1 to 3782 | exact | RefSeq, AAA | | 3782/3782 (100 %) | 0 diff (100 %id) |
CR747277 | leiomyosarcoma, uterus | .f | 86 to 570 | 10 to 494 | | tiling clone, | | 485/494 (98 %) | 6 diff (98.8 %id) |
BM803516 | leiomyosarcoma, uterus | .f | 90 to 693 | 1 to 607 | | | | 607/1087 (55 %) | 36 diff (96.7 %id) |
CB960480 | Human Placenta, placenta | .f | 297 to 1021 | 22 to 744 | | tiling clone, | | 723/803 (90 %) | 11 diff (98.7 %id) |
NM_022074.3 | | .g | 1 to 3591 | 2 to 3592 | exact | RefSeq, AAA | | 3592/3592 (100 %) | 0 diff (100 %id) |
DA502464 | brain | .g | 1 to 553 | 2 to 554 | | tiling clone, capped | | 553/554 (99 %) | 1 diff (99.9 %id) |
AK291453 | brain | .g | 34 to 2350 | 1 to 2317 | exact | tiling clone, | | 2317/2317 (100 %) | 0 diff (100 %id) |
DA805239 | brain | .g | 35 to 555 | 2 to 522 | | capped | | 521/521 (100 %) | 0 diff (100 %id) |
DA245590 | brain | .g | 48 to 637 | 2 to 591 | | capped | | 590/590 (100 %) | 0 diff (100 %id) |
BU193891 | melanotic melanoma, skin | .g | 49 to 947 | 1 to 904 | | | | 904/904 (100 %) | 7 diff (99.3 %id) |
BF898611 | marrow | .g | 51 to 490 | 453 to 17 | | | Submitted on the opposite strand | 437/455 (96 %) | 4 diff (99.2 %id) |
DA653956 | | .g | 57 to 611 | 2 to 557 | | capped | | 556/556 (100 %) | 1 diff (99.9 %id) |
CN372412 | embryonic stem cells, cell lines H1, H7, andH9 | .g | 64 to 554 | 1 to 492 | | | | 492/492 (100 %) | 1 diff (99.8 %id) |
DB125350 | thymus | .g | 84 to 661 | 2 to 580 | | capped | | 579/579 (100 %) | 1 diff (99.9 %id) |
DA645423 | | .g | 88 to 659 | 2 to 573 | | capped | | 572/572 (100 %) | 0 diff (100 %id) |
BF795976 | lymph, lymphoma, cell line | .g | 97 to 779 | 1 to 690 | | AAA | | 690/952 (72 %) | 18 diff (98.2 %id) |
DB321763 | | .g | 3063 to 3591 | 529 to 1 | | tiling clone, | | 529/529 (100 %) | 0 diff (100 %id) |
NM_001142521.1 | | .h | 1 to 3595 | 1 to 3595 | exact | RefSeq, AAA | | 3595/3595 (100 %) | 0 diff (100 %id) |
AV733763 | pheochromocytoma | .h | 92 to 569 | 1 to 469 | | tiling clone, | | 469/470 (99 %) | 10 diff (97.9 %id) |
BG991811 | head_neck | .h | 302 to 427 | 15 to 140 | | | | 126/140 (90 %) | 6 diff (95.8 %id) |
DA457720 | tongue, tumor tissue | .h | 329 to 897 | 2 to 570 | | capped | | 569/569 (100 %) | 1 diff (99.9 %id) |
DA799286 | brain | .h | 329 to 873 | 2 to 546 | | capped | | 545/545 (100 %) | 1 diff (99.9 %id) |
CA395994 | eye, RPE/choroid | .h | 399 to 989 | 1 to 591 | | tiling clone, | | 591/591 (100 %) | 0 diff (100 %id) |
D30891 | | .h | 413 to 672 | 1 to 260 | | | | 260/260 (100 %) | 6 diff (97.7 %id) |
AW500647 | lymph | .h | 483 to 995 | 1 to 513 | | | | 513/513 (100 %) | 3 diff (99.5 %id) |
TI_154154868 | | .h | 490 to 1165 | 80 to 754 | | | | 675/676 (99 %) | 6 diff (99.2 %id) |
CK000484 | mixed | .h | 551 to 1352 | 8 to 806 | | | | 799/815 (98 %) | 7 diff (99.2 %id) |
BG259646 | embryonal carcinoma, cell line, testis | .h | 575 to 1403 | 1 to 840 | | | | 840/988 (85 %) | 41 diff (95.9 %id) |
CN372414 | embryonic stem cells, DMSO-treated H9 cellline | .h | 634 to 1136 | 1 to 503 | | | | 503/503 (100 %) | 0 diff (100 %id) |
DW436082 | Liver | .h | 678 to 922 | 10 to 253 | | | | 244/253 (96 %) | 6 diff (97.7 %id) |
BX485923 | | .h | 688 to 1318 | 1 to 631 | | | | 631/631 (100 %) | 3 diff (99.6 %id) |
FN150861 | breast carcinoma | .h | 710 to 813 | 103 to 1 | | | Submitted on the opposite strand | 103/106 (97 %) | 8 diff (92.5 %id) |
BF898223 | marrow | .h | 745 to 1038 | 303 to 11 | | | Submitted on the opposite strand | 293/303 (96 %) | 0 diff (100 %id) |
BM752149 | Ascites, stomach | .h | 751 to 1320 | 1 to 571 | | | | 571/571 (100 %) | 7 diff (98.8 %id) |
AW168848 | moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus | .h | 763 to 1183 | 422 to 1 | | | | 422/422 (100 %) | 9 diff (97.9 %id) |
AW168877 | moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus | .h | 773 to 1179 | 411 to 4 | | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 408/411 (99 %) | 0 diff (100 %id) |
AI521118 | serous papillary carcinoma, high grade, 2pooled tumors, uterus | .h | 792 to 1169 | 378 to 1 | | | | 378/378 (100 %) | 0 diff (100 %id) |
DN995778 | breast cancer, Mammary gland (cancer tissue) | .h | 795 to 1357 | 8 to 569 | | | | 562/569 (98 %) | 6 diff (99.0 %id) |
BC013137 | Testis, embryonal carcinoma | .h | 808 to 3595 | 1 to 2785 | | tiling clone, available from MGC, AAA | | 2785/2785 (100 %) | 2 diff (100.0 %id) |
BG258662 | embryonal carcinoma, cell line, testis | .h | 809 to 1572 | 1 to 750 | | available from MGC, | | 750/919 (81 %) | 18 diff (98.1 %id) |
TI_57165422 | | .h | 817 to 1526 | 31 to 745 | | | | 715/745 (95 %) | 6 diff (99.2 %id) |
BI837719.
matches multiple genes | Pancreas, Spleen, adult pooled, pooled pancreas and spleen | .h | 821 to 1526 | 1 to 711 | | available from MGC, | Suspected internal deletion, suspected internal deletion, this clone was ignored, also hits gene C2orf18andCENPA | 711/711 (100 %) | 15 diff (97.9 %id) |
AK092953 | Spleen | .h | 824 to 3595 | 1 to 2774 | | tiling clone, available from FLJ, | | 2774/2774 (100 %) | 2 diff (100.0 %id) |
AX747824 | | .h | 824 to 3595 | 1 to 2774 | | | | 2774/2774 (100 %) | 2 diff (100.0 %id) |
DA938517 | Spleen | .h | 825 to 1421 | 2 to 599 | | capped | | 598/598 (100 %) | 1 diff (99.9 %id) |
BQ331434 | lung_tumor | .h | 861 to 1316 | 460 to 6 | | | | 455/460 (98 %) | 0 diff (100 %id) |
DA685313 | | .h | 977 to 1530 | 2 to 557 | | capped | | 556/556 (100 %) | 2 diff (99.7 %id) |
BE093915 | breast | .h | 993 to 1454 | 69 to 527 | | | | 459/527 (87 %) | 6 diff (98.9 %id) |
BF857655 | prostate_tumor | .h | 1034 to 1430 | 1 to 398 | | | | 398/398 (100 %) | 10 diff (97.5 %id) |
BI045107 | prostate_normal | .h | 1055 to 1402 | 358 to 11 | | | | 348/358 (97 %) | 0 diff (100 %id) |
BC041693 | Testis, embryonal carcinoma | .h | 1086 to 3595 | 1 to 2506 | | available from MGC, AAA | | 2506/2506 (100 %) | 3 diff (99.9 %id) |
BI254113 | cervical carcinoma cell line, cervix | .h | 1087 to 1781 | 1 to 711 | | | | 711/1078 (65 %) | 23 diff (97.9 %id) |
BM543333 | embryonal carcinoma, cell line, testis | .h | 1087 to 2007 | 1 to 932 | | available from MGC, | | 932/1086 (85 %) | 29 diff (97.4 %id) |
EC557213 | Prostate | .h | 1103 to 1171 | 1 to 69 | | | | 69/72 (95 %) | 1 diff (98.7 %id) |
AW752798 | colon | .h | 1107 to 1675 | 1 to 570 | | | | 570/570 (100 %) | 21 diff (96.4 %id) |
AW850750 | colon | .h | 1108 to 1638 | 1 to 532 | | | | 532/532 (100 %) | 7 diff (98.7 %id) |
BE143707 | head_neck | .h | 1114 to 1644 | 21 to 549 | | | | 529/549 (96 %) | 6 diff (99.0 %id) |
BE143640 | head_neck | .h | 1121 to 1709 | 10 to 596 | | | | 587/596 (98 %) | 6 diff (99.0 %id) |
AW752800 | colon | .h | 1122 to 1633 | 1 to 512 | | | | 512/512 (100 %) | 0 diff (100 %id) |
AW752815 | colon | .h | 1122 to 1629 | 1 to 508 | | | | 508/514 (98 %) | 1 diff (99.9 %id) |
DA047627 | | .h | 1135 to 1711 | 2 to 580 | | capped | | 579/579 (100 %) | 2 diff (99.7 %id) |
DB333009 | Spleen | .h | 3198 to 3595 | 399 to 1 | | | | 399/399 (100 %) | 1 diff (99.8 %id) |
DA492024 | brain | .i | 1 to 546 | 2 to 547 | | tiling clone, capped | | 546/546 (100 %) | 6 diff (99.0 %id) |
DB241945 | stomach, tumor tissue | .i | 520 to 1077 | 2 to 559 | | tiling clone, capped | | 558/558 (100 %) | 0 diff (100 %id) |
DB143006 | thymus | .i | 615 to 1108 | 2 to 495 | | capped | | 494/494 (100 %) | 0 diff (100 %id) |
DA411396 | thalamus | .i | 962 to 1521 | 2 to 561 | | tiling clone, capped | | 560/560 (100 %) | 0 diff (100 %id) |
BG109946 | Bone, osteosarcoma, cell line | .i | 1127 to 1907 | 1 to 784 | | | | 784/1039 (75 %) | 18 diff (98.3 %id) |
AB067482 | brain | .i | 1191 to 5186 | 1 to 3992 | exact | tiling clone, available from KIAA, | | 3992/3992 (100 %) | 2 diff (100.0 %id) |
BQ378960 | uterus_tumor | .i | 1340 to 1829 | 495 to 6 | | | | 490/495 (98 %) | 0 diff (100 %id) |
DB350635 | stomach, tumor tissue | .i | 2491 to 2760 | 274 to 1 | | | | 274/274 (100 %) | 5 diff (98.2 %id) |
DA956085 | Spleen | .i | 2779 to 3337 | 2 to 561 | | capped | | 560/560 (100 %) | 1 diff (99.9 %id) |
BF170242 | blood | .i | 2832 to 3071 | 1 to 241 | | | | 241/241 (100 %) | 10 diff (95.9 %id) |
AW752708 | colon | .i | 2944 to 3574 | 631 to 1 | | | | 631/638 (98 %) | 0 diff (100 %id) |
BE143872 | head_neck | .i | 2973 to 3585 | 627 to 14 | | | Submitted on the opposite strand | 614/627 (97 %) | 0 diff (100 %id) |
AK026447 | ileal mucosa | .i | 2984 to 5186 | 1 to 2199 | | available from FLJ, AAA | | 2199/2199 (100 %) | 6 diff (99.8 %id) |
AA386056 | Pancreas | .i | 3023 to 3364 | 1 to 343 | | | | 343/343 (100 %) | 2 diff (99.5 %id) |
AW752728 | colon | .i | 3039 to 3574 | 536 to 1 | | | | 536/536 (100 %) | 9 diff (98.4 %id) |
CN372413 | embryonic stem cells, DMSO-treated H9 cellline | .i | 3054 to 3779 | 9 to 736 | | | | 728/736 (98 %) | 6 diff (99.2 %id) |
BC054515 | Lung, Spleen, fetal, pooled | .i | 3090 to 5186 | 1 to 2099 | | available from MGC, AAA | | 2099/2099 (100 %) | 2 diff (100.0 %id) |
BI769935 | pooled lung and spleen | .i | 3090 to 3810 | 1 to 724 | | available from MGC, | | 724/724 (100 %) | 6 diff (99.2 %id) |
TI_57183359 | | .i | 3090 to 3810 | 39 to 762 | | | | 724/762 (95 %) | 6 diff (99.3 %id) |
CR998655 | T-Lymphocytes | .i | 3124 to 3643 | 1 to 519 | | | | 519/519 (100 %) | 3 diff (99.5 %id) |
BP292084 | lung | .i | 3152 to 3721 | 1 to 570 | | | | 570/570 (100 %) | 3 diff (99.5 %id) |
CB985728 | Pooled-Glandular | .i | 3176 to 3830 | 1 to 664 | | | | 664/859 (77 %) | 17 diff (98.1 %id) |
AK025319 | colon | .i | 3186 to 5186 | 14 to 2014 | | available from FLJ, AAA | | 2001/2001 (100 %) | 3 diff (99.9 %id) |
BP221443 | colon | .i | 3186 to 3758 | 1 to 573 | | | | 573/573 (100 %) | 2 diff (99.7 %id) |
AW752823 | colon | .i | 3194 to 3779 | 586 to 1 | | | | 586/586 (100 %) | 1 diff (99.9 %id) |
AK130799 | thymus | .i | 3274 to 5186 | 1 to 1907 | | available from FLJ, | | 1907/1907 (100 %) | 5 diff (99.8 %id) |
BF910470 | uterus_tumor | .i | 3290 to 3588 | 45 to 344 | | | | 300/346 (86 %) | 22 diff (93.7 %id) |
BE143836 | head_neck | .i | 3306 to 3679 | 378 to 4 | | | Submitted on the opposite strand | 375/378 (99 %) | 0 diff (100 %id) |
CF994387 | Human Placenta, placenta | .i | 3315 to 3989 | 28 to 698 | | | | 671/711 (94 %) | 11 diff (98.5 %id) |
BI257859 | cervical carcinoma cell line, cervix | .i | 3329 to 4019 | 1 to 693 | | | | 693/799 (86 %) | 7 diff (99.2 %id) |
BX490423 | | .i | 3353 to 3760 | 1 to 408 | | | | 408/411 (99 %) | 2 diff (99.6 %id) |
BP292657 | lung | .i | 3370 to 3951 | 1 to 582 | | | | 582/582 (100 %) | 9 diff (98.5 %id) |
CN302730 | embryonic stem cells, DMSO-treated H9 cellline | .i | 3390 to 3863 | 1 to 471 | | | | 471/471 (100 %) | 1 diff (99.8 %id) |
BP379683 | uterus | .i | 3417 to 3993 | 1 to 581 | | | | 581/581 (100 %) | 23 diff (96.1 %id) |
N25145 | melanocyte | .i | 3449 to 3958 | 1 to 512 | | | | 512/513 (99 %) | 2 diff (99.7 %id) |
BF214529 | bone marrow, from acute myelogenous leukemia | .i | 3505 to 3978 | 1 to 477 | | | | 477/1145 (41 %) | 9 diff (99.3 %id) |
BQ881989 | dorsal root ganglia | .i | 3598 to 4516 | 24 to 948 | | | | 925/952 (97 %) | 20 diff (97.9 %id) |
R56506 | whole brain | .i | 3602 to 4015 | 1 to 419 | | | | 419/430 (97 %) | 7 diff (98.4 %id) |
BG026766 | Bone, osteosarcoma, cell line | .i | 3627 to 4150 | 1 to 531 | | | | 531/971 (54 %) | 29 diff (97.1 %id) |
BP367291 | thymus | .i | 3657 to 4238 | 1 to 584 | | | | 584/584 (100 %) | 7 diff (98.9 %id) |
CD722704 | eye, lacrimal gland | .i | 3678 to 4074 | 1 to 395 | | | | 395/395 (100 %) | 1 diff (99.8 %id) |
BQ719545 | sympathetic trunk | .i | 3692 to 4610 | 1 to 924 | | tiling clone, | | 924/927 (99 %) | 48 diff (94.9 %id) |
CA407668 | adipose | .i | 3707 to 3871 | 1 to 165 | | | | 165/165 (100 %) | 0 diff (100 %id) |
CN372416 | embryonic stem cells, cell lines H1, H7, andH9 | .i | 3711 to 4029 | 1 to 319 | | | | 319/319 (100 %) | 1 diff (99.7 %id) |
CN372417 | embryonic stem cells, cell lines H1, H7, andH9 | .i | 3711 to 4029 | 1 to 319 | | | | 319/319 (100 %) | 2 diff (99.4 %id) |
TI_149296410 | | .i | 3911 to 4564 | 758 to 119 | | | | 640/946 (67 %) | 0 diff (100 %id) |
CD511847 | Pooled-Skin | .i | 3920 to 4709 | 1 to 804 | | | | 804/820 (98 %) | 27 diff (96.8 %id) |
TI_154134032 | | .i | 4015 to 4370 | 89 to 445 | | | Submitted on the opposite strand | 357/1146 (31 %) | 7 diff (99.4 %id) |
AW576324 | lymph | .i | 4020 to 4370 | 1 to 351 | | | Submitted on the opposite strand | 351/398 (88 %) | 3 diff (99.3 %id) |
BQ002072 | Chondrosarcoma, Left Pubic Bone | .i | 4031 to 4697 | 1 to 667 | | | Submitted on the opposite strand | 667/667 (100 %) | 2 diff (99.8 %id) |
AA465228 | germinal center B cell | .i | 4037 to 4452 | 1 to 416 | | | Submitted on the opposite strand | 416/416 (100 %) | 0 diff (100 %id) |
BU684362 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .i | 4056 to 4564 | 566 to 59 | | AAA | | 508/551 (92 %) | 0 diff (100 %id) |
AA430754 | | .i | 4115 to 4552 | 1 to 438 | | | | 438/438 (100 %) | 0 diff (100 %id) |
BF245071 | brain, glioblastoma | .i | 4127 to 4828 | 1 to 698 | | | | 698/846 (82 %) | 25 diff (97.1 %id) |
AW390464 | stomach | .i | 4161 to 4778 | 625 to 7 | | | | 619/625 (99 %) | 0 diff (100 %id) |
EC470959 | Prostate | .i | 4176 to 4271 | 111 to 19 | | | | 93/111 (83 %) | 0 diff (100 %id) |
EC486313 | Prostate | .i | 4176 to 4275 | 106 to 11 | | | | 96/106 (90 %) | 0 diff (100 %id) |
BF668656 | brain, primitive neuroectoderm | .i | 4188 to 4872 | 1 to 680 | | | | 680/694 (97 %) | 13 diff (98.2 %id) |
TI_151772653 | | .i | 4214 to 4871 | 98 to 760 | | | | 663/1221 (54 %) | 20 diff (98.4 %id) |
C03131 | heart | .i | 4221 to 4614 | 23 to 417 | | | | 395/417 (94 %) | 7 diff (98.4 %id) |
AA088809 | colon, tumor | .i | 4232 to 4590 | 1 to 359 | | | | 359/359 (100 %) | 0 diff (100 %id) |
CB108848 | Liver | .i | 4261 to 4787 | 1 to 526 | | | | 526/526 (100 %) | 1 diff (99.9 %id) |
TI_149307759 | | .i | 4277 to 5186 | 988 to 95 | | AAA | | 894/954 (93 %) | 32 diff (96.7 %id) |
TI_149286664 | | .i | 4322 to 5189 | 959 to 98 | | | | 862/1228 (70 %) | 0 diff (100 %id) |
AA281196 | germinal center B cell | .i | 4331 to 4527 | 1 to 197 | | | | 197/197 (100 %) | 0 diff (100 %id) |
BE924960 | amnion_normal | .i | 4350 to 4736 | 390 to 3 | | | | 388/615 (63 %) | 0 diff (100 %id) |
CN372411 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .i | 4393 to 5152 | 1 to 758 | | | | 758/758 (100 %) | 6 diff (99.3 %id) |
AW383617 | head_neck | .i | 4406 to 4742 | 339 to 2 | | | | 338/339 (99 %) | 0 diff (100 %id) |
BG171688 | hypernephroma, cell line, Kidney | .i | 4431 to 5183 | 1 to 747 | | AAA | | 747/747 (100 %) | 17 diff (97.8 %id) |
BF920617 | nervous_tumor | .i | 4432 to 4698 | 308 to 39 | | | Submitted on the opposite strand | 525/581 (90 %) | 19 diff (96.8 %id) |
BP197977 | adrenal gland | .i | 4441 to 5023 | 1 to 583 | | | | 583/583 (100 %) | 0 diff (100 %id) |
W31510 | parathyroid gland, parathyroid tumor | .i | 4442 to 4636 | 1 to 196 | | | | 196/196 (100 %) | 1 diff (99.5 %id) |
BX091275 | liver and spleen | .i | 4447 to 5186 | 1 to 740 | | AAA | | 740/740 (100 %) | 1 diff (99.9 %id) |
FN088147 | breast carcinoma | .i | 4447 to 4556 | 108 to 1 | | | Submitted on the opposite strand | 108/108 (100 %) | 2 diff (98.2 %id) |
TI_154137060 | | .i | 4447 to 5193 | 832 to 84 | | AAA | | 749/908 (82 %) | 33 diff (96.4 %id) |
AW383538 | head_neck | .i | 4470 to 4749 | 286 to 10 | | | | 277/286 (96 %) | 0 diff (100 %id) |
TI_149294190 | | .i | 4475 to 5186 | 789 to 78 | | AAA | | 712/712 (100 %) | 4 diff (99.5 %id) |
FN165201 | breast carcinoma | .i | 4481 to 4580 | 97 to 1 | | | Submitted on the opposite strand | 97/98 (98 %) | 3 diff (97.0 %id) |
AA215876 | | .i | 4484 to 4725 | 1 to 242 | | | | 242/244 (99 %) | 3 diff (98.8 %id) |
CR738453 | placenta | .i | 4484 to 5166 | 1 to 683 | | | | 683/683 (100 %) | 0 diff (100 %id) |
R39390 | placenta | .i | 4484 to 4860 | 1 to 388 | | | | 388/396 (97 %) | 20 diff (95.0 %id) |
BQ775662 | Bone, Human Chondrosarcoma Cell Line | .i | 4490 to 5186 | 714 to 17 | | AAA | | 698/698 (100 %) | 6 diff (99.2 %id) |
BU682996 | lung | .i | 4496 to 5186 | 707 to 17 | | AAA | | 691/691 (100 %) | 1 diff (99.9 %id) |
BU933252 | mixed (pool of 40 RNAs) | .i | 4502 to 5131 | 1 to 636 | | | | 636/816 (77 %) | 14 diff (98.3 %id) |
BE896234 | melanotic melanoma, skin | .i | 4505 to 5179 | 1 to 675 | | | | 675/675 (100 %) | 6 diff (99.2 %id) |
EC546596 | Prostate | .i | 4544 to 4655 | 1 to 113 | | | | 113/113 (100 %) | 3 diff (97.4 %id) |
BG388006 | embryonal carcinoma, cell line, testis | .i | 4571 to 5186 | 1 to 612 | | AAA | | 612/612 (100 %) | 5 diff (99.2 %id) |
BY994074 | | .i | 4575 to 5189 | 665 to 51 | | | Submitted on the opposite strand | 615/665 (92 %) | 0 diff (100 %id) |
BF033003 | adenocarcinoma, ovary | .i | 4592 to 5185 | 9 to 603 | | | | 595/603 (98 %) | 6 diff (99.1 %id) |
BM979479 | lung, Primary Lung Epithelial Cells | .i | 4612 to 5186 | 592 to 18 | | AAA | | 575/575 (100 %) | 0 diff (100 %id) |
BF969572 | adrenal cortex carcinoma, cell line, adrenal gland | .i | 4628 to 5186 | 1 to 558 | | AAA | | 558/558 (100 %) | 1 diff (99.9 %id) |
AA372416 | colon | .i | 4631 to 4920 | 1 to 290 | | | | 290/290 (100 %) | 3 diff (99.0 %id) |
AA948676 | 2 pooled tumors (clear cell type), Kidney | .i | 4647 to 5189 | 544 to 2 | | | | 543/544 (99 %) | 0 diff (100 %id) |
BM972197 | lung | .i | 4655 to 5186 | 550 to 19 | | AAA | | 532/532 (100 %) | 4 diff (99.3 %id) |
AW968406 | | .i | 4682 to 5189 | 558 to 51 | | | Submitted on the opposite strand | 508/559 (90 %) | 0 diff (100 %id) |
AI031966 | parathyroid gland, parathyroid tumor | .i | 4685 to 5186 | 521 to 16 | | AAA | | 506/506 (100 %) | 6 diff (98.9 %id) |
AI916558 | Kidney | .i | 4685 to 5187 | 503 to 1 | | | | 503/503 (100 %) | 2 diff (99.7 %id) |
TI_149282965 | | .i | 4686 to 5186 | 639 to 139 | | AAA | | 501/801 (62 %) | 3 diff (99.7 %id) |
BU679997 | lung, Primary Lung Epithelial Cells | .i | 4686 to 5186 | 517 to 17 | | AAA | | 501/509 (98 %) | 3 diff (99.5 %id) |
AW338928 | adenocarcinoma, Pancreas | .i | 4691 to 5193 | 503 to 1 | | | | 503/503 (100 %) | 0 diff (100 %id) |
BM669613 | eye, fetal eyes | .i | 4696 to 5186 | 509 to 19 | | AAA | | 491/491 (100 %) | 9 diff (98.2 %id) |
AW473646 | poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus | .i | 4703 to 5189 | 488 to 2 | | | | 487/488 (99 %) | 0 diff (100 %id) |
AA433947 | | .i | 4709 to 5186 | 488 to 11 | | AAA | | 478/478 (100 %) | 0 diff (100 %id) |
N20955 | melanocyte | .i | 4713 to 5186 | 480 to 1 | | | | 480/484 (99 %) | 8 diff (98.4 %id) |
BM459443 | lymph, lymphoma, cell line | .i | 4714 to 5189 | 519 to 41 | | | Submitted on the opposite strand | 479/1113 (43 %) | 0 diff (100 %id) |
AA281071 | germinal center B cell | .i | 4720 to 5187 | 468 to 1 | | | | 468/468 (100 %) | 0 diff (100 %id) |
AW939005 | denis_drash | .i | 4721 to 5033 | 319 to 9 | | | Submitted on the opposite strand | 311/319 (97 %) | 7 diff (97.9 %id) |
AI810867 | Prostate | .i | 4727 to 5186 | 460 to 1 | | | | 460/460 (100 %) | 0 diff (100 %id) |
BE348759 | carcinoid, lung | .i | 4729 to 5194 | 466 to 1 | | tiling clone, | | 466/466 (100 %) | 0 diff (100 %id) |
AI870252 | uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors | .i | 4730 to 5184 | 478 to 24 | | AAA | | 455/455 (100 %) | 7 diff (98.5 %id) |
AA815306 | | .i | 4736 to 5189 | 455 to 2 | | | | 454/455 (99 %) | 0 diff (100 %id) |
H98625 | melanocyte | .i | 4740 to 5186 | 449 to 1 | | | | 449/449 (100 %) | 2 diff (99.6 %id) |
R05526 | liver and spleen | .i | 4741 to 5183 | 454 to 1 | | | | 454/454 (100 %) | 17 diff (96.3 %id) |
R56113 | whole brain | .i | 4748 to 5186 | 453 to 12 | | AAA | | 442/444 (99 %) | 11 diff (97.6 %id) |
AA088670 | colon, tumor | .i | 4755 to 5186 | 443 to 1 | | | | 443/445 (99 %) | 17 diff (96.2 %id) |
AW571767 | uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors | .i | 4756 to 5186 | 447 to 17 | | AAA | | 431/431 (100 %) | 2 diff (99.6 %id) |
AA635997 | normal prostate, Prostate | .i | 4768 to 4994 | 227 to 1 | | | | 227/227 (100 %) | 1 diff (99.6 %id) |
AI148682 | placenta | .i | 4768 to 5186 | 430 to 12 | | AAA | | 419/419 (100 %) | 0 diff (100 %id) |
AI244696 | Kidney | .i | 4768 to 5186 | 418 to 1 | | | | 418/428 (97 %) | 2 diff (99.6 %id) |
BE092847 | breast | .i | 4771 to 5164 | 395 to 2 | | | Submitted on the opposite strand | 394/395 (99 %) | 0 diff (100 %id) |
AA534742 | colon | .i | 4773 to 5186 | 416 to 1 | | | | 416/425 (97 %) | 21 diff (95.1 %id) |
AI191230 | lung | .i | 4778 to 5189 | 415 to 4 | | | | 412/415 (99 %) | 0 diff (100 %id) |
AI934930 | 2 pooled tumors (clear cell type), Kidney | .i | 4779 to 5189 | 411 to 1 | | | | 411/411 (100 %) | 8 diff (98.1 %id) |
AI700266 | colon | .i | 4780 to 5181 | 412 to 11 | | AAA | | 402/402 (100 %) | 1 diff (99.8 %id) |
BE221218 | malignant melanoma, metastatic to lymphnode, skin | .i | 4785 to 5186 | 412 to 11 | | AAA | | 402/402 (100 %) | 0 diff (100 %id) |
AI219015 | placenta | .i | 4787 to 5187 | 401 to 1 | | | | 401/402 (99 %) | 5 diff (98.8 %id) |
AI039972 | senescent fibroblast | .i | 4799 to 5189 | 393 to 3 | | | | 391/393 (99 %) | 0 diff (100 %id) |
AI192409 | uterus | .i | 4806 to 5037 | 232 to 1 | | | | 232/232 (100 %) | 0 diff (100 %id) |
AW024404 | Kidney | .i | 4807 to 5186 | 380 to 1 | | | | 380/380 (100 %) | 3 diff (99.3 %id) |
W04611 | parathyroid gland, parathyroid tumor | .i | 4810 to 5189 | 386 to 5 | | | | 382/388 (98 %) | 0 diff (100 %id) |
AA860574 | parathyroid gland, parathyroid tumor | .i | 4810 to 5189 | 384 to 5 | | | | 380/384 (98 %) | 0 diff (100 %id) |
AI681244 | carcinoid, lung | .i | 4811 to 5186 | 401 to 26 | | AAA | | 376/376 (100 %) | 8 diff (97.9 %id) |
AI268589 | carcinoid, lung | .i | 4813 to 5186 | 399 to 26 | | AAA | | 374/374 (100 %) | 9 diff (97.6 %id) |
C16581 | | .i | 4814 to 5184 | 1 to 371 | | | | 371/371 (100 %) | 1 diff (99.8 %id) |
BE092623 | breast | .i | 4843 to 5145 | 8 to 311 | | | | 304/311 (97 %) | 6 diff (98.1 %id) |
BF061053 | fibrotheoma, ovary | .i | 4845 to 5186 | 342 to 1 | | | | 342/342 (100 %) | 1 diff (99.8 %id) |
R38299 | placenta | .i | 4846 to 5173 | 344 to 1 | | | | 344/388 (88 %) | 23 diff (94.1 %id) |
AI623642 | adenocarcinoma, Pancreas | .i | 4847 to 5186 | 354 to 15 | | AAA | | 340/340 (100 %) | 1 diff (99.8 %id) |
AJ713805 | bone marrow | .i | 4861 to 4974 | 1 to 114 | | | | 114/114 (100 %) | 0 diff (100 %id) |
BE816365 | breast_normal | .i | 4870 to 5176 | 323 to 17 | | | | 307/331 (92 %) | 0 diff (100 %id) |
BF747835 | breast | .i | 4871 to 4986 | 123 to 10 | | | Submitted on the opposite strand | 114/141 (80 %) | 0 diff (100 %id) |
AA470441 | colon | .i | 4873 to 5186 | 314 to 1 | | | | 314/314 (100 %) | 1 diff (99.7 %id) |
BE011190 | breast_normal | .i | 4877 to 5162 | 286 to 1 | | | Submitted on the opposite strand | 286/286 (100 %) | 0 diff (100 %id) |
BE011218 | breast_normal | .i | 4877 to 5162 | 287 to 1 | | | Submitted on the opposite strand | 287/287 (100 %) | 3 diff (99.0 %id) |
BE011222 | breast_normal | .i | 4877 to 5122 | 298 to 59 | | | Submitted on the opposite strand | 240/298 (80 %) | 0 diff (100 %id) |
AW135098 | | .i | 4878 to 5186 | 324 to 16 | | AAA | | 309/309 (100 %) | 0 diff (100 %id) |
AI201833 | Prostate | .i | 4892 to 5186 | 295 to 1 | | | | 295/295 (100 %) | 2 diff (99.4 %id) |
AA907768 | lung, small cell carcinoma | .i | 4893 to 5186 | 324 to 31 | | AAA | | 294/295 (99 %) | 0 diff (100 %id) |
BE816371 | breast_normal | .i | 4898 to 5162 | 1 to 259 | | | | 259/259 (100 %) | 9 diff (96.6 %id) |
AA465584 | germinal center B cell | .i | 4902 to 5187 | 286 to 1 | | | Submitted on the opposite strand | 286/286 (100 %) | 0 diff (100 %id) |
N62420 | multiple sclerosis lesions | .i | 4905 to 5186 | 282 to 1 | | | | 282/282 (100 %) | 1 diff (99.7 %id) |
R38314 | placenta | .i | 4909 to 5139 | 235 to 1 | | | | 235/241 (97 %) | 4 diff (98.4 %id) |
AA904266 | lung, small cell carcinoma | .i | 4918 to 5186 | 299 to 31 | | AAA | | 269/269 (100 %) | 0 diff (100 %id) |
BE816358 | breast_normal | .i | 4924 to 5115 | 9 to 204 | | | | 196/209 (93 %) | 14 diff (93.4 %id) |
EC543130 | Prostate | .i | 4939 to 5043 | 1 to 105 | | | | 105/105 (100 %) | 0 diff (100 %id) |
BE092859 | breast | .i | 4940 to 5147 | 1 to 208 | | | | 208/208 (100 %) | 3 diff (98.6 %id) |
EC538989 | Prostate | .i | 4941 to 5045 | 1 to 105 | | | | 105/105 (100 %) | 0 diff (100 %id) |
CA446849 | Chondrosarcoma, Left Pubic Bone | .i | 4941 to 5186 | 262 to 17 | | AAA | | 246/246 (100 %) | 1 diff (99.6 %id) |
AI762009 | Kidney | .i | 4986 to 5189 | 208 to 5 | | | | 204/208 (98 %) | 0 diff (100 %id) |
CV363163 | breast_normal | .i | 5018 to 5153 | 133 to 1 | | | Submitted on the opposite strand | 133/133 (100 %) | 11 diff (91.8 %id) |
AA827837 | germinal center B cell | .i | 5024 to 5186 | 197 to 35 | | AAA | | 163/163 (100 %) | 0 diff (100 %id) |
FN118916 | breast carcinoma | .i | 5038 to 5146 | 109 to 1 | | | Submitted on the opposite strand | 109/109 (100 %) | 0 diff (100 %id) |
EC559335 | Prostate | .i | 5083 to 5185 | 105 to 3 | | | | 103/105 (98 %) | 0 diff (100 %id) |
AK092237 | | .j | 1 to 3755 | 6 to 3760 | | tiling clone, available from FLJ, | | 3760/3760 (100 %) | 5 diff (99.9 %id) |
AX747422 | | .j | 1 to 3755 | 6 to 3760 | | | | 3760/3760 (100 %) | 5 diff (99.9 %id) |
DA740175 | | .j | 1 to 515 | 6 to 520 | | capped | | 519/519 (100 %) | 0 diff (100 %id) |
DA950734 | Spleen | .j | 1 to 553 | 2 to 554 | | capped | | 553/553 (100 %) | 0 diff (100 %id) |
DA796749 | brain | .j | 31 to 582 | 2 to 553 | | capped | | 552/552 (100 %) | 0 diff (100 %id) |
DA193761 | amygdala | .j | 79 to 650 | 2 to 573 | | capped | | 572/572 (100 %) | 1 diff (99.9 %id) |
R84941 | eye, retina | .j | 137 to 475 | 1 to 341 | | | | 341/348 (97 %) | 5 diff (98.6 %id) |
CN288982 | embryonic stem cells, DMSO-treated H9 cellline | .j | 368 to 1086 | 1 to 718 | | tiling clone, | | 718/718 (100 %) | 2 diff (99.8 %id) |
BI832923 | pooled pancreas and spleen | .j | 388 to 1136 | 1 to 747 | | | | 747/747 (100 %) | 3 diff (99.6 %id) |
TI_57168470 | | .j | 388 to 1136 | 36 to 782 | | | | 747/782 (95 %) | 8 diff (99.0 %id) |
DA440262 | tongue, tumor tissue | .j | 684 to 1255 | 2 to 573 | | capped | | 572/572 (100 %) | 0 diff (100 %id) |
DA386492 | thalamus | .j | 896 to 1476 | 2 to 582 | | capped | | 581/581 (100 %) | 1 diff (99.9 %id) |
F00207 | leg muscle, skeletal muscle | .j | 1202 to 1410 | 88 to 296 | | | | 209/296 (70 %) | 6 diff (98.0 %id) |
BE222032 | Kidney | .j | 1347 to 1875 | 529 to 1 | | tiling clone, | | 529/529 (100 %) | 0 diff (100 %id) |
AA768864 | germinal center B cell | .j | 1357 to 1796 | 440 to 1 | | | | 440/440 (100 %) | 2 diff (99.6 %id) |
Z24963 | leg muscle, skeletal muscle | .j | 1360 to 1693 | 335 to 2 | | | | 334/335 (99 %) | 0 diff (100 %id) |
AA969945 | pooled | .j | 1363 to 1803 | 440 to 1 | | | | 440/440 (100 %) | 4 diff (99.1 %id) |
AA814003 | germinal center B cell | .j | 1380 to 1799 | 420 to 1 | | | | 420/420 (100 %) | 1 diff (99.8 %id) |
AA883909 | parathyroid gland, parathyroid tumor | .j | 1386 to 1825 | 440 to 1 | | | | 440/440 (100 %) | 0 diff (100 %id) |
BE675421 | B-cell, chronic lymphotic leukemia | .j | 1393 to 1875 | 483 to 1 | | | | 483/483 (100 %) | 2 diff (99.6 %id) |
BE999944 | colon, colon tumor, RER+ | .j | 1409 to 1857 | 449 to 1 | | | | 449/449 (100 %) | 4 diff (99.2 %id) |
AI439614 | B-cell, chronic lymphotic leukemia | .j | 1410 to 1875 | 466 to 1 | | | | 466/466 (100 %) | 0 diff (100 %id) |
AW301207 | Kidney | .j | 1410 to 1875 | 466 to 1 | | | | 466/466 (100 %) | 0 diff (100 %id) |
AA830008 | germinal center B cell | .j | 1417 to 1776 | 360 to 1 | | | | 360/360 (100 %) | 0 diff (100 %id) |
AW058020 | thymus, pooled | .j | 1417 to 1857 | 441 to 1 | | | | 441/441 (100 %) | 0 diff (100 %id) |
AI290188 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .j | 1423 to 1875 | 453 to 1 | | | | 453/453 (100 %) | 0 diff (100 %id) |
AI760900 | B-cell, chronic lymphotic leukemia | .j | 1442 to 1816 | 375 to 1 | | | | 375/375 (100 %) | 13 diff (96.6 %id) |
AA688159 | germinal center B cell | .j | 1472 to 1719 | 248 to 1 | | | | 248/248 (100 %) | 0 diff (100 %id) |
AW134948 | | .j | 1473 to 1874 | 402 to 1 | | | | 402/402 (100 %) | 3 diff (99.3 %id) |
AI301638 | 2 pooled tumors (clear cell type), Kidney | .j | 1474 to 1875 | 402 to 1 | | | | 402/402 (100 %) | 0 diff (100 %id) |
AI867850 | pooled germ cell tumors | .j | 1510 to 1847 | 340 to 1 | | | | 340/341 (99 %) | 2 diff (99.5 %id) |
AA828554 | germinal center B cell | .j | 1541 to 1792 | 252 to 1 | | | | 252/252 (100 %) | 0 diff (100 %id) |
AA642367 | germinal center B cell | .j | 1569 to 1794 | 226 to 1 | | | | 226/226 (100 %) | 1 diff (99.6 %id) |
AW138071 | | .j | 1624 to 1874 | 251 to 1 | | | | 251/251 (100 %) | 0 diff (100 %id) |
AI222153 | pooled | .j | 1868 to 2144 | 1 to 277 | | tiling clone, | Submitted on the opposite strand | 277/332 (83 %) | 8 diff (97.6 %id) |
BE676491 | B-cell, chronic lymphotic leukemia | .j | 1877 to 2114 | 1 to 240 | | | Submitted on the opposite strand | 240/240 (100 %) | 2 diff (99.2 %id) |
AI457429 | carcinoid, lung | .j | 1887 to 2121 | 1 to 234 | | | Submitted on the opposite strand | 234/234 (100 %) | 3 diff (98.8 %id) |
AI769351 | pooled | .j | 1887 to 2169 | 1 to 282 | | | Submitted on the opposite strand | 282/282 (100 %) | 5 diff (98.3 %id) |
AW241889 | pooled | .j | 1932 to 2152 | 1 to 221 | | | Submitted on the opposite strand | 221/221 (100 %) | 0 diff (100 %id) |
AA730051 | germinal center B cell | .j | 1960 to 2170 | 1 to 211 | | | Submitted on the opposite strand | 211/211 (100 %) | 2 diff (99.1 %id) |
CR749358 | uterus endothel, primary cell culture | .j | 1983 to 6179 | 1 to 4196 | exact | tiling clone, available from DKFZ, AAA | | 4196/4196 (100 %) | 1 diff (100.0 %id) |
BX112128 | pooled | .j | 1987 to 2384 | 404 to 3 | | | Submitted on the opposite strand | 402/409 (98 %) | 0 diff (100 %id) |
BF819293 | colon_ins | .j | 2297 to 2578 | 312 to 29 | | | Submitted on the opposite strand | 284/312 (91 %) | 0 diff (100 %id) |
BI004499 | head_normal | .j | 2333 to 2588 | 21 to 271 | | | | 251/271 (92 %) | 6 diff (97.8 %id) |
DB313662 | tongue, tumor tissue | .j | 3208 to 3755 | 550 to 1 | | | | 550/550 (100 %) | 2 diff (99.7 %id) |
DB324653 | | .j | 3486 to 3755 | 272 to 1 | | | | 272/272 (100 %) | 3 diff (98.9 %id) |
BU507018 | leiomyosarcoma, uterus | .k | 1 to 766 | 61 to 829 | P2S S3G Y42F I188L H223P ... | tiling clone, AAA | | 769/1052 (73 %) | 26 diff (97.6 %id) |
BU941516 | mixed (pool of 40 RNAs) | .l | 1 to 422 | 1 to 422 | exact | tiling clone, | | 422/450 (93 %) | 3 diff (99.4 %id) |
BI767118 | pooled lung and spleen | .m | 1 to 610 | 1 to 610 | L43C L44C P45L E46K E47R ... | tiling clone, | | 610/610 (100 %) | 3 diff (99.6 %id) |
TI_57178795 | | .m | 1 to 610 | 36 to 645 | L43C L44C P45L E46K E47R ... | | | 610/645 (94 %) | 9 diff (98.7 %id) |
BM923741 | pooled colon, kidney, stomach | .m | 87 to 941 | 40 to 905 | | tiling clone, | | 866/1095 (79 %) | 22 diff (98.0 %id) |
CR742832 | parathyroid gland, parathyroid tumor | .m | 267 to 1042 | 1 to 776 | | tiling clone, | | 776/776 (100 %) | 2 diff (99.8 %id) |
DB227218 | trachea | .m | 281 to 781 | 2 to 502 | | capped | | 501/501 (100 %) | 0 diff (100 %id) |
BU595830 | mixed (pool of 40 RNAs) | .n | 1 to 693 | 8 to 715 | S25L S26C L27C F29K K30S ... | tiling clone, | | 715/893 (80 %) | 24 diff (97.4 %id) |
BE560448 | Burkitt lymphoma, lymph | .o | 1 to 678 | 1 to 680 | exact | tiling clone, | | 680/880 (77 %) | 23 diff (97.4 %id) |
BQ948815 | leiomyosarcoma, uterus | .p | 1 to 911 | 6 to 919 | L108S N109Q T110H L111S Q112P ... | tiling clone, | | 919/920 (99 %) | 23 diff (97.5 %id) |
DA723513 | | .p | 266 to 840 | 2 to 577 | | tiling clone, capped | | 576/576 (100 %) | 1 diff (99.9 %id) |
TI_57239121 | | .q | 1 to 888 | 26 to 912 | exact | tiling clone, | | 887/913 (97 %) | 17 diff (98.2 %id) |
BI915108 | brain | .q | 7 to 888 | 1 to 881 | exact | tiling clone, | | 881/882 (99 %) | 11 diff (98.8 %id) |
BQ420366 | embryonal carcinoma, cell line, testis | .r | 1 to 776 | 2 to 781 | Q122P I138L M142N P143G L144P ... | tiling clone, | | 781/898 (86 %) | 11 diff (98.8 %id) |
DA326596 | hippocampus | .s | 1 to 563 | 2 to 564 | exact | tiling clone, capped | | 563/563 (100 %) | 1 diff (99.9 %id) |
CN277937 | embryonic stem cells, DMSO-treated H9 cellline | .s | 39 to 407 | 1 to 369 | exact | | | 369/369 (100 %) | 0 diff (100 %id) |
DA480686 | | .s | 112 to 669 | 2 to 559 | exact | tiling clone, capped | | 558/558 (100 %) | 0 diff (100 %id) |
DA991607 | synovial membrane tissue from rheumatioidarthritis | .s | 122 to 666 | 2 to 546 | exact | capped | | 545/545 (100 %) | 0 diff (100 %id) |
AV759399 | bone marrow | .s | 188 to 586 | 1 to 391 | | | | 391/391 (100 %) | 7 diff (98.3 %id) |
DA318827 | hippocampus | .t | 1 to 504 | 2 to 506 | R29X V31C S33Q A34R A35S ... | tiling clone, capped | | 505/505 (100 %) | 1 diff (99.9 %id) |
DA182954 | amygdala | .t | 7 to 569 | 2 to 564 | exact | capped | | 563/563 (100 %) | 0 diff (100 %id) |
DA292662 | hippocampus | .t | 19 to 584 | 2 to 567 | exact | capped | | 566/566 (100 %) | 3 diff (99.5 %id) |
DB292105 | uterus | .t | 31 to 609 | 2 to 580 | exact | capped | | 579/579 (100 %) | 1 diff (99.9 %id) |
DA447311 | tongue, tumor tissue | .t | 35 to 609 | 2 to 576 | exact | tiling clone, capped | | 575/575 (100 %) | 0 diff (100 %id) |
DB271726 | uterus | .t | 64 to 632 | 2 to 570 | | tiling clone, capped | | 569/569 (100 %) | 3 diff (99.5 %id) |
DB129831 | thymus | .u | 1 to 578 | 2 to 579 | exact | tiling clone, capped | | 578/578 (100 %) | 0 diff (100 %id) |
AA236604 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .u | 131 to 312 | 1 to 182 | | | | 182/182 (100 %) | 0 diff (100 %id) |
BF368915 | placenta_normal | .u | 160 to 399 | 254 to 22 | | | | 233/254 (91 %) | 1 diff (99.7 %id) |
DB234701 | trachea | .va | 1 to 576 | 2 to 577 | exact | tiling clone, capped | | 576/576 (100 %) | 0 diff (100 %id) |
DB161448 | thymus | .vb | 1 to 573 | 2 to 574 | exact | tiling clone, capped | | 573/573 (100 %) | 0 diff (100 %id) |
DA717324 | | .vc | 1 to 552 | 2 to 553 | exact | tiling clone, capped | | 552/552 (100 %) | 0 diff (100 %id) |
DA327883 | hippocampus | .vd | 1 to 549 | 2 to 550 | exact | tiling clone, capped | | 549/549 (100 %) | 0 diff (100 %id) |
DA648638 | | .ve | 1 to 544 | 2 to 546 | exact | tiling clone, capped | | 545/545 (100 %) | 1 diff (99.9 %id) |
DB217136 | trachea | .vf | 1 to 535 | 2 to 538 | exact | tiling clone, capped | | 537/537 (100 %) | 2 diff (99.7 %id) |
BU428612 | lymph | .vg | 1 to 307 | 5 to 311 | N18K N34D | tiling clone, | | 311/311 (100 %) | 5 diff (98.4 %id) |
AK092061 | | Gene FAM111BandFAM111A, variant not shown | | | | available from FLJ, | This clone was ignored | | |
AW850550 | colon | Gene FAM111BandFAM111A, variant not shown | | | | | Suspected internal deletion, this clone was ignored | | |
AX747338 | | Gene FAM111BandFAM111A, variant not shown | | | | | This clone was ignored | | |
BC071759 | Pooled, 40 cell lines | Gene FAM111BandFAM111A, variant not shown | | | | available from MGC, AAA | This clone was ignored | | |
DB371016 | ovary, tumor tissue | Gene FAM111BandFAM111A, variant not shown | | | | | This clone was ignored | | |
DA811785 | ovary, tumor tissue | Gene FAM111BandFAM111A, variant not shown | | | | capped | This clone was ignored | | |
? | Gene Summary |
Gene on genome |
mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va, .vb, .vc, .vd, .ve, .vf, .vg |
Alternative mRNAs features, proteins, introns, exons, sequences |
Expression Tissue |
Function, regulation, related genes C |
To mine knowledge about the gene, please click the 'Gene Summary' or the 'Function, regulation, related genes ' tab at the top of the page. The 'Gene Summary' page includes all we learnt about the gene, functional annotations of neighboring genes, maps, links to other sites and the bibliography. The 'Function, regulation, related genes ' page includes Diseases (D), Pathways, GO annotations, conserved domains (C), interactions (I) reference into function, and pointers to all genes with the same functional annotation.
To compare alternative variants, their summarized annotations, predicted proteins, introns and exons, or to access any sequence, click the 'Alternative mRNAs features' tab. To see a specific mRNA variant diagram, sequence and annotation, click the variant name in the 'mRNA' tab. To examine expression data from all cDNAs clustered in this gene by AceView, click the 'Expression tissue'.
If you know more about this gene, or found errors, please share your knowledge. Thank you !